نتائج البحث

Chemoradiotherapy versus radiotherapy in high risk salivary gland cancer.

• Authors : Shen, Yicheng¹ (AUTHOR); Shan, Jiebo¹ (AUTHOR)

• Source: World Journal of Surgical Oncology. 7/11/2024, Vol. 22 Issue 1, p1-10. 10p.

تفاصيل العنوان

Disease distribution and temporal trends of salivary gland cancer: A global population‐based study.

• Authors : Huang, Junjie^1,2 (AUTHOR); Fung, Yat Ching¹ (AUTHOR); Pang, Wing Sze¹ (AUTHOR)

• Source: Clinical & Translational Medicine. May2024, Vol. 14 Issue 5, p1-6. 6p.

تفاصيل العنوان

Near-Infrared Photoimmunotherapy Using a Protein Mimetic for EGFR-Positive Salivary Gland Cancer.

• Authors : Yamaguchi, Haruka¹ (AUTHOR) ; Suzuki, Takamasa² (AUTHOR) ; Okada, Yasuo³ (AUTHOR)

Subjects: *SALIVARY gland cancer; *PHOTOTHERMAL effect; *NEAR infrared radiation

• Source: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 6, p3233. 15p.

تفاصيل العنوان

Defining the relationship of salivary gland malignancies to novel cell subpopulations in human salivary glands using single nucleus RNA‐sequencing

• Authors : Nakagawa, Takuya; Santos, Jessica; Nasamran, Chanond A

Subjects: Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Cancer

• Source: International Journal of Cancer. 154(8)

تفاصيل العنوان

Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

• Source: Phase II Study of Pemetrexed and Pembrolizumab in Recurrent and/or Metastatic Salivary Gland Malignancies

تفاصيل العنوان

Characterization of Diseases With Salivary Gland Involvement

• Source: Characterization of Diseases With Salivary Gland Involvement

تفاصيل العنوان

Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers (INDAGA-UK)

• Source: Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers: The INDAGA-UK Trial

تفاصيل العنوان

Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma

• Authors : Merck Sharp & Dohme LLC; Manish Patel, Sponsor-Investigator

• Source: Phase II Trial of Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland

تفاصيل العنوان

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

• Authors : Genentech, Inc.; Glenn J. Hanna, Principal Investigator

• Source: A Phase II Study of Adjuvant Ado-trastuzumab Emtansine (T-DM1) in HER2-positive Salivary Gland Carcinomas

تفاصيل العنوان

Testing the Anti-Cancer Drug Darolutamide in Patients With Testosterone-driven Salivary Gland Cancers

• Source: A Phase 2 Study of Darolutamide in Combination With Leuprolide Acetate in Hormone-Therapy Naïve Recurrent and/or Metastatic Androgen Receptor (AR) Positive Salivary

تفاصيل العنوان